Fiera Capital (Canada)
ADPT icon

Fiera Capital (Canada)’s Adaptive Biotechnologies ADPT Stock Holding History

Fiera Capital (Canada)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35,948
Closed -$499K – 578
2022
Q1 		$499K Sell
35,948
-1,358
-4% -$21.4K ﹤0.01% 519
2021
Q4 		$1.05M Sell
37,306
-3,144
-8% -$96.4K ﹤0.01% 414
2021
Q3 		$1.37M Sell
40,450
-507
-1% -$18.3K ﹤0.01% 334
2021
Q2 		$1.67M Sell
40,957
-2,893
-7% -$112K ﹤0.01% 322
2021
Q1 		$1.76M Sell
43,850
-34,284
-44% -$1.86M 0.01% 314
2020
Q4 		$4.62M Buy
78,134
+3,569
+5% +$184K 0.01% 251
2020
Q3 		$3.63M Buy
74,565
+10,485
+16% +$441K 0.01% 259
2020
Q2 		$3.1M Buy
+64,080
New +$2.34M 0.01% 274

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Fiera Capital (Canada)'s ADPT Position: Q2 2022 in Review

Fiera Capital (Canada) sold out of Adaptive Biotechnologies (ADPT) in Q2 2022, closing a stake of 35,948 shares — an estimated $499K sold.

Fiera Capital (Canada) first reported a position in ADPT in Q2 2020 and held it in 8 quarters. The position peaked at $4.62M in Q4 2020. 209 funds tracked by Wall St. Rank hold ADPT as of Q2 2022.

  • Fiera Capital (Canada) reported no remaining Adaptive Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • Fiera Capital (Canada) sold 35,948 Adaptive Biotechnologies shares in Q2 2022, an estimated $499K.
  • Fiera Capital (Canada) first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 8 quarters.
  • Fiera Capital (Canada)'s Adaptive Biotechnologies position peaked at $4.62M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2022.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2022, filed 10 Aug 2022.